Teleflex Incorporated

Biopharma merger and acquisition value for the first quarter of 2025 reached $38.4bn from 41 transactions, 22 of which had disclosed values. Making up almost 38% of that total was Johnson & Johnso

Biopharma Acquisitions Biopharma merger and acquisition value for the third quarter of 2022 reached $15.4bn from 41 transactions, 21 of which had disclosed values. Four M&A transactions hit or exceede

A cardiac catheter from Teleflex Incorporated subsidiary Arrow International Inc. is the subject of a high-risk class I recall due to the risk of tip damage during use, the US Food and Drug Admini

After cutting the physician fee for the Glaukos Corporation iStent well below what analysts had expected last week, the US Centers for Medicare & Medicaid Services (CMS) delivered another potential